Cdc4 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc4 monoclonal antibodies for research in cell cycle regulation and protein degradation. Cdc4 Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc4, also known as cell division cycle 4, plays a crucial role in the ubiquitin-proteasome pathway, facilitating the degradation of specific proteins that regulate the cell cycle. Cdc4 maintains proper cell division and prevents uncontrolled cell proliferation, which can lead to cancer. Understanding Cdc4 function is vital for elucidating the mechanisms of tumorigenesis and developing targeted therapies. Researchers worldwide rely on Cdc4 monoclonal antibodies to investigate cellular pathways and protein interactions. Advanced detection methods include conjugation with horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced visualization. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of cell cycle regulation and contribute to the development of innovative cancer treatments.